Estadístiques de Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

Visites totals

views
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study 13

Visites totals per mes

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 13
December 2025 0

Visites al fitxer

views
Rodriguez_eo_indu.pdf 28